Cholinesterase inhibitors in Alzheimer's disease : Are they worth the cost?WHITEHOUSE, P. J.CNS drugs. 1999, Vol 11, Num 3, pp 167-173, issn 1172-7047Article

Cholinergic therapy in dementiaWHITEHOUSE, P. J.Acta neurologica Scandinavica. Supplementum. 1993, Vol 88, Num 149, pp 42-45, issn 0065-1427Article

The cholinergic deficit in Alzheimer's diseaseWHITEHOUSE, P. J.The Journal of clinical psychiatry. Supplement. 1998, Vol 59, Num 13, pp 19-22Conference Paper

Cholinergic receptors in aging and Alzheimer's diseaseWHITEHOUSE, P. J; KIN SING AU.Progress in neuro-psychopharmacology & biological psychiatry. 1986, Vol 10, Num 3-5, pp 665-676, issn 0278-5846Article

Harmony and consensus : Cultural aspects of organization in international science : International working group for the harmonization of dementia drug guidelines reportGAINES, A. D; WHITEHOUSE, P. J.Alzheimer disease and associated disorders. 1998, Vol 12, Num 4, pp 295-301, issn 0893-0341Article

Nicotinic cholinergic receptors associated with mammalian cerebral vesselsKALARIA, R. N; HOMAYOUN, P; WHITEHOUSE, P. J et al.Journal of the autonomic nervous system. 1994, Vol 49, pp S3-S7, issn 0165-1838, SUPArticle

Dementia : nosology and brain-behavior relationshipsCHATTERJEE, A; MACK, J; WHITEHOUSE, P. J et al.Dementia. 1991, Vol 2, Num 2, pp 116-120, 5 p.Article

Current concepts : Evaluation of dementiaGELDMACHER, D. S; WHITEHOUSE, P. J.The New England journal of medicine. 1996, Vol 335, Num 5, pp 330-336, issn 0028-4793Article

Future prospects for Alzheimer's disease therapy : ethical and policy issues for the international communityWHITEHOUSE, P. J.Acta neurologica Scandinavica. Supplementum. 1996, Vol 93, Num 165, pp 145-149, issn 0065-1427Article

Donepezil and flight simulator performance: Effects on retention of complex skillsYESAVAGE, J. A; MUMENTHALER, M. S; TAYLOR, J. L et al.Neurology. 2002, Vol 59, Num 1, pp 123-125, issn 0028-3878Article

Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsyTABATON, M; WHITEHOUSE, P. J; PERRY, G et al.Annals of neurology. 1988, Vol 24, Num 3, pp 407-413, issn 0364-5134Article

Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's diseaseDE SOUZA, E. B; WHITEHOUSE, P. J; FOLSTEIN, S. E et al.Brain research. 1987, Vol 437, Num 2, pp 355-359, issn 0006-8993Article

Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortexKELLAR, K. J; WHITEHOUSE, P. J; MARTINO-BARROWS, A. M et al.Brain research. 1987, Vol 436, Num 1, pp 62-68, issn 0006-8993Article

Corticotropin-releasing factor receptors in human pituitary gland: autoradiographic localizationDE SOUZA, E. B; PERRIN, M. H; WHITEHOUSE, P. J et al.Neuroendocrinology (Basel). 1985, Vol 40, Num 5, pp 419-422, issn 0028-3835Article

Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementiaPRICE, D. L; KITT, C. A; STRUBLE, R. G et al.Annals of the New York Academy of Sciences. 1985, Vol 457, pp 35-51, issn 0077-8923Article

Neurobiological markers of memory lossARNSTEN, A. F. T; GOLDMAN-RAKIC, P. S; CORK, L. C et al.Annals of the New York Academy of Sciences. 1985, Vol 444, pp 218-295, issn 0077-8923Article

Genesis of Alzheimer's diseaseWHITEHOUSE, P. J.Neurology. 1997, Vol 48, Num 5, pp S2-S7, issn 0028-3878, SUP7Article

Dementia and the life-prolonging technologies used : an ethical questionPOST, S. G; WHITEHOUSE, P. J.Alzheimer disease and associated disorders. 1992, Vol 6, Num 1, pp 3-6, issn 0893-0341Article

Harmonization of dementia drug guidelines (United States and Europe) : A report of the International Working Group for the Harmonization for Dementia Drug GuidelinesWHITEHOUSE, P. J.Alzheimer disease and associated disorders. 2000, Vol 14, pp S119-S122, issn 0893-0341, SUP1Conference Paper

Emerging antidementia drugs : A preliminary ethical viewPOST, S. G; WHITEHOUSE, P. J.Journal of the American Geriatrics Society. 1998, Vol 46, Num 6, pp 784-787, issn 0002-8614Article

Is the placebo control obsolete in a world after donepezil and vitamin E?KARLAWISH, J. H. T; WHITEHOUSE, P. J.Archives of neurology (Chicago). 1998, Vol 55, Num 11, pp 1420-1424, issn 0003-9942Article

Pharmacoeconomics of dementia. DiscussionWHITEHOUSE, P. J; BODICK, N. C; LEVKOFF, S et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp S22-S33, issn 0893-0341, SUP5Conference Paper

First international pharmacoeconomic conference on Alzheimer's disease : Report and summary : International working group for the harmonization of dementia drug guidelines reportWHITEHOUSE, P. J; WINBLAD, B; HAY, J et al.Alzheimer disease and associated disorders. 1998, Vol 12, Num 4, pp 266-280, issn 0893-0341Article

Measurement choices in multi-site studies of outcomes in dementiaSMYTH, K. A; FERRIS, S. H; FOX, P et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp 30-44, issn 0893-0341, SUP6Conference Paper

Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugsGELDMACHER, D. S; LERNER, A. J; VOCI, J. M et al.Journal of geriatric psychiatry and neurology. 1997, Vol 10, Num 3, pp 99-104, issn 0891-9887Article